glutathione sjogren's syndrome Primary Sjögren's Salivary gland protective and antiinflammatory

Antioxidant defence mechanisms: from the beginning to the end (of the beginning)

Do you understand the difference between preclinical animal research and human clinical trial evidence

Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor alpha and fundamentally changing lipid metabolism

It promotes weight loss through multiple mechanisms: reducing appetite and food intake via central nervous system effects, slowing gastric emptying, and improving glycemic control through glucosedependent insulin secretion [1][3]

In the current study, we showed that inhibition of TH by continuous low dose -MT administration initiated at the early stage was able to prevent LRRK2 G2019S mutation induced DA neurodegeneration in our PD models